Conexeu Sciences Inc.

US$2.26As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:CNXUHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE (332.94%)
Biotechnology
Beta (5Y) —
PE TTM —
TSR TTM —
Mkt cap US$69.68M
ROIC (190.88%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$2.85
25.89%
(79.44%)
Hold 9|3|1|11|9
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.03
0.02
0.03
0.03
5.89%
(5.07%)
0.92%
11.35%
Revenue$M
5.521
5.583
5.775
5.736
(1.06%)
(2.31%)
0.40%
2.37%
Peers (US$69.68M)
Cap (US$)
PE
71.86M
—
Capital
TTM
5Y
10Y
Leveragex
4.598
(0.628)
(0.559)
EBIT/Intx
0.141
0.191
0.166
Own earn%
67.64
141.56
106.61
Sh yield%
42.16
45.18
40.06
Owners
Insiders/Inst%
12.59
60.46
Short interest%
3.73
SBC / revenue%
2.73
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
10
Op margin range%
16–21
$1 testx
—
Incr. ROIC%
6